Early management of suspected bacterial meningitis and meningococcal septicaemia in adults

Journal of Infection

Volumn 46, Issue 2, 2003, Pages 75-77

  Heyderman, R S ^a   Lambert, H P ^b   O'Sullivan, I ^b   Stuart, J M ^b   Taylor, B L ^b   Wall, R A ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ANTIGEN; CORTICOSTEROID; DEXAMETHASONE; MENINGOCOCCUS VACCINE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MENINGITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUING EDUCATION; DRUG EFFICACY; EMERGENCY WARD; FEVER; HEADACHE; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; IMMUNIZATION; LUMBAR PUNCTURE; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; MENINGOCOCCEMIA; MORBIDITY; MORTALITY; NEISSERIA MENINGITIDIS; PATIENT CARE; PATIENT REFERRAL; PETECHIA; POSTGRADUATE EDUCATION; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PROGNOSIS; RASH; SHOCK; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM; VOMITING;

EID: 0037320099     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1053/jinf.2002.1110     Document Type: Article

References (32)

1. Balmer P, Borrow R, Miller E. Impact of meningococcal C conjugate vaccine in the UK. J Med Microbiol 2002; 51: 717-122.
2. http://www.phls.co.uk/facts/Mening/index.htm
3. Pizza M, Scarlato V, Masignani V, Giuliani MM, Arico B, Comanducci M et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000; 287: 1816-1820.
4. Grifantini R, Bartolini E, Muzzi A, Draghi M, Frigimelica E, Berger J et al. Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays. Nat Biotechnol 2002; 20: 914-921.
5. Kizil G, Todd I, Atta M, Borriello SP, Ait-Tahar K, Ala'Aldeen DA. Identification and characterization of TspA, a major CD4(+) T-cell-and B-cell-stimulating Neisseria-specific antigen. Infect Immun 1999; 67: 3533-3541.
6. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000; 19: 187-195.
7. Heyderman RS, Klein NJ. Emergency management of meningitis. J R Soc Med 2000; 93: 225-229.
8. Strang JR, Pugh EJ. Meningococcal infections: reducing the case fatality rate by giving penicillin before admission to hospital. BMJ 1992; 305: 141-143.
9. Cartwright K, Reilly S, White D, Stuart J. Early treatment with parenteral penicillin in meningococcal disease. BMJ 1992; 305: 143-147.
10. Riordan FA, Thomson AP, Sills JA, Hart CA. Who spots the spots? Diagnosis and treatment of early meningococcal disease in children. BMJ 1996; 313: 1255-1256.
11. Nadel S, Britto J, Booy R, Maconochie I, Habibi P, Levin M. Avoidable deficiencies in the delivery of health care to children with meningococcal disease. J Accid Emerg Med 1998; 15: 298-303.
12. Granier S, Owen P, Pill R, Jacobson L. Recognising meningococcal disease in primary care: qualitative study of how general practitioners process clinical and contextual information. BMJ 1998; 316: 276-279.
13. Pollard AJ, Britto J, Nadel S, DeMunter C, Habibi P, Levin M. Emergency management of meningococcal disease. Arch Dis Child 1999; 80: 290-296.
14. Hodgetts TJ, Brett A, Castle N. The early management of meningococcal disease. J Accid Emerg Med 1998; 15: 72-76.
15. Booy R, Habibi P, Nadel S, de Munter C, Britto J, Morrison A et al. Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery. Arch Dis Child 2001; 85: 386-390.
16. Thorburn K, Baines P, Thomson A, Hart CA. Mortality in severe meningococcal disease. Arch Dis Child 2001; 85: 382-385.
17. Begg N, Cartwright KA, Cohen J, Kaczmarski EB, Innes JA, Leen CL et al. Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults. British Infection Society Working Party. J Infect 1999; 39: 1-15.
18. Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS Jr. et al. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993; 328: 21-28.
19. Sigurdardottir B, Bjornsson OM, Jonsdottir KE, Erlendsdottir H, Gudmundsson S. Acute bacterial meningitis in adults. A 20-year overview. Arch Int Med 1997; 157: 425-430.
20. Kneen R, Solomon T, Appleton R. The role of lumbar puncture in suspected CNS infection-a disappearing skill? Arch Dis Child 2002; 87: 181-183.
21. Kanegaye JT, Soliemanzadeh P, Bradley JS. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment. Pediatrics 2001; 108: 1169-1174.
22. Blazer S, Berant M, Alon U. Bacterial meningitis. Effect of antibiotic treatment on cerebrospinal fluid. Am J Clin Pathol 1983; 80: 386-387.
23. Hasbun R, Abrahams J, Jekel J, Quagliarello VJ. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med 2001; 345: 1727-1733.
24. Heyderman RS, Robb SA, Kendall BE, Levin M. Does computed tomography have a role in the evaluation of complicated acute bacterial meningitis in childhood? Dev Med Child Neurol 1992; 34: 870-875.
25. van Furth AM, Roord JJ, van Furth R. Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy. Infect Immun 1996; 64: 4883-4890.
26. Meli DN, Christen S, Leib SL, Tauber MG. Current concepts in the pathogenesis of meningitis caused by Streptococcus pneumoniae. Curr Opin Infect Dis 2002; 15: 253-257.
27. Rosenstein NE, Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med 2001; 344: 1378-1388.
28. Brandtzaeg P, van Deuren M. Current concepts in the role of the host response in Neisseria meningitidis septic shock. Curr Opin Infect Dis 2002; 15: 247-252.
29. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709.
30. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. Jama 2002; 288: 862-871.
31. de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002; 347: 1549-1556.
32. Tunkel AR, Scheld WM. Corticosteroids for everyone with meningitis? N Engl J Med 2002; 347: 1613-1615.